Resume

Sign in

Registered Nurse Customer Service

Location:
Camp Hill, PA, 17011
Posted:
January 29, 2019

Contact this candidate

Resume:

DANIELLE SCHADE BSN,RN

**** ***** *****• CAMP HILL, PA 17011

PHONE 717-***-****

E-MAIL: ac8bzd@r.postjobfree.com

PROFILE

~ Goal driven and focused Registered Nurse with a diverse and extensive medical background in various clinical settings. Skilled in therapeutic communication. Self-motivated with high energy. Insight into the needs and views of others; able to listen and identify issues or problem areas to form innovative solutions.

Key strengths include:

• Proficient Documentation Skills and use of Microsoft Office, various electronic data capture (EDC) & electronic medical record (EMR) systems such as EPIC, RAVE, INFORM, ORACLE, Medidata, IXRS-ALMAC, etc.

• Functions as a Key Advocate for Patients

• Enjoys Building Relationships with Patients, Families & Team Members

• Efficiently Prioritizes Patient Care and Safety

• Flexible, Assertive & Adaptable when Reacting to Emergency Situations.

• Thorough Knowledge of Medical Equipment and Latest Advancements

• Ability to Educate Patients Regarding Diet, Nutrition & Exercise Regime

• Proficiency of Pathophysiology and Dysrhythmia Interpretation

WORK EXPERIENCE

2015- Present ~ Geisinger Holy Spirit Cardiology –Camp Hill, PA

Clinical Research Coordinator -Registered Nurse

Coordinates Multiple Research Trials for Cardiac Related Medications & Devices

Works within the scope of the Code of Federal Regulations by applying Good Clinical practices to contribute to the process for “New Device” approval or “New Drug” approval from the Food and Drug Administration.

Complex Cardiovascular Catheter Therapeutics- Annual Advanced Endovascular and Coronary Intervention Global Summit Representative/Attendee

2011 - 2015 ~ Holy Spirit Hospital – Invasive Cardiology Camp Hill, PA

Registered Nurse

Advanced Cardiac Life Support & Critical Care Course Certified

Collaborates with Physicians to Develop Cardiac Rehabilitation Treatment Plans

Monitors Patient Physical Responses, Behavioral Changes and Reports to Physicians

Telecommunication & Bedside Education with Patients Pre-operatively and Post-operatively

Direct Contribution to Patient Satisfaction and Excellence in Customer Service

Independently Analyzes Patient Needs and Provides Appropriate Plan of Treatment by Correlating Knowledge with Community Health Situations

Member of the Relationship Based Care/Magnet Recognition Committee

2011 ~ Highmark Blue Shield Camp Hill, PA

Nurse Appeals Analyst -Medicare Chart Reviews

Reviewed and Analyzed Claims from a Medical Perspective.

Decision Making for Healthcare Claims and Monetary Payment processing

Application of Standard Concepts as Outlined in Current Healthcare Policies & Procedures for Medicare

Identification of Quality Related Problems

Recommendation of Process Improvements Designed to Improve Accuracy and Timeliness

EDUCATION

2011-2014 Pennsylvania State University University Park, PA

Bachelor of Science in Nursing

2008-2010Excelsior College Albany, NY

Associate Degree in Nursing

2006-2007 Harrisburg Area Community College Harrisburg, PA

Licensed Practical Nursing

1999-2001 Bloomsburg University Bloomsburg, PA

Bachelor of Science in Nursing

Member of Theta Tau Omega

CERTIFICATIONS

Basic life Support (BLS) for Healthcare Providers

Advanced Cardiac Life Support (ACLS)

AHA Stroke Scale

NIH Training

RANKIN Scale

CITI – Good Clinical Practice (exp. 2.24.2020)

AAI -Dermal Fillers for Facial Enhancement: Fundamental Techniques Aesthetic Applications of Neurotoxins: Fundamental Techniques- trained at the Advanced Aesthetic Institute. CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare.

CLINICAL RESEARCH TRIALS

ABSORB III & IV: Abbott Vascular; trial compares Absorb study stent to commercially approved stent for treating coronary artery lesions; 2015; 2016; 2017; 2018 & 2019.

ACCELERATE: Lilly & Cleveland Clinic; Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes. 2015 & 2016.

AEGIS II: CSL Behring &DCRI. A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome. 2017, 2018 & 2019.

ANTELOPE: TriReme; An Assessment of the Glider Balloon in Complex Lesions. 2015; 2016 & 2017.

ARTEMIS: Astra Zeneca & DCRI; Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study. 2015; 2016 & 2017.

BIOFLEX: Biotronik; Evaluation of Astron Pulsar and Astron stents for iliac and femoral popliteal lesions; 2015; 2016 & 2017.

CHOCOLATE: TriReme; A Randomized Trial to confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated PTA Balloon Catheter, in Above the Knee Lesions. 2016; 2017, 2018 & 2019.

CIRT: National Heart Lung and Blood Institute; evaluation of the effectiveness of methotrexate in reducing cardiovascular events in type 2 diabetics; 2015; 2016; 2017; 2018 & 2019.

CONFIDENCE: Microvention; Carotid Stent Trial to Evaluate the Safety and Efficacy of the Roadsaver Stent used in conjunction with the Nanoparasol Embolic Protection System for patients at Increased Risk for Adverse Events from Carotid Endartectomy. 2016; 2017; 2018 & 2019.

EUCLID: Astra Zeneca; study to compare effectiveness of ticagrelor and clopidogrel in patients with peripheral artery disease; 2015 & 2016.

HEART-FID: Luitpold & DCRI. A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency, an Iron vs. Placebo Infusion. 2017, 2018 & 2019.

IC-HOT: SSO2 Therapy: A Multicenter evaluation of the delivery of the intracoronary hyperoxemic supersaturated oxygen therapy for 60 minutes in the anterior acute myocardial infarction patients with successful reperfusion (via PCI) < six hours after symptom onset; Ther-Ox, Inc. 2015 & 2016.

IN.PACT SFA II: Medtronic; study of new Medtronic drug-eluding balloon used in treating PAD in the SFA/PPA; 2015; 2016; 2017; 2018 & 2019.

ISCHEMIA: NYU & NIH/NHLBI; International Study of Comparative Health Effectiveness with Medical and Invasive Approaches; National Heart, Lung and Blood Institute (NHLBI) 2015; 2016; 2017; 2018 & 2019.

ODYSSEY: Sanofi US; evaluation of effect of SAR236553/REGN727 for preventing reoccurrence of cardiovascular events; 2015; 2016 & 2017.

PIONEER AF PCI: Janssen Scientific Affairs LLC; Open-label, randomized, multicenter clinical study assessing the safety of 2 Rivoroxaban treatment strategies and one VKA treatment strategy in men & women who have paroxysmal, persistent, or permanent non-valvular AF and have had a PCI with stent placement; 2015; 2016 & 2017.

REVEAL: REX Medical; To evaluate the safety and effectiveness of the Revolution™ Peripheral Atherectomy System in the treatment of infrainguinal lower extremity peripheral arterial occlusive disease. 2017, 2018 & 2019.

SCAFFOLD: W.L. Gore & Associates; study of the Gore stent used in treatment of carotid artery stenosis. 2015; 2016; 2017; 2018 & 2019.

TOBA II: Intact Vascular; Tack Optimized Balloon Angioplasty Study for the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular system. 2016; 2017; 2018 & 2019.

TRANSCEND: Surmodics; To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries. 2018 & 2019.

VIABAHN BX: Gore; expandable balloon endoprosthesis for the treatment of occlusive disease in the common and External Iliac Artery. 2015; 2016; 2017; 2018 & 2019.

XACT CAROTID Physician IDE G #040160 – RN facilitator for FDA submission for single center carotid stenting using “angiomax” for “low risk” patient population. 2015; 2016; 2017 & 2018.

XIENCE 90 DAPT: Abbott. Evaluate the safety of taking blood thinners for 3 months & aspirin with no specified time limit after stent placement in patients with CAD. 2017, 2018 & 2019.

ZILVER PTX V: Cook Medical; study of the safety and effectiveness of drug-eluding stent in femoropopliteal artery. 2015; 2016; 2017; 2018 & 2019.

REFERENCES

Available upon request.



Contact this candidate